Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 19:50 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Stroke Prevention With Abciximab in Carotid Endarterectomy
NCT00178451 · University of Rochester · PHASE1/PHASE2 · withdrawn · last registry update 2015-12-18 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, University of Rochester |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against ITGB3 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2016-04-28Results posted on the registry: National Cancer Institute (NCI), cilengitide (NCT00121238)
- 2016-03-30Results posted on the registry: Merck KGaA, Darmstadt, Germany, EMD 525797 250 mg + EMD 525797 500 mg (NCT01008475)
- 2016-02-25Results posted on the registry: National Cancer Institute (NCI), cilengitide + temozolomide (NCT00085254)
- 2016-02-12Results posted on the registry: The Medicines Company, Bivalirudin + Heparin (NCT01087723)
- 2015-12-14Results posted on the registry: Merck KGaA, Darmstadt, Germany, EMD 525797 (NCT00848510)
- 2015-12-14Results posted on the registry: EMD Serono, EMD 525797 + EMD 525797 (NCT01360840)
- 2015-07-21Also stopped (terminated): Martin-Luther-Universität Halle-Wittenberg, Cilengitide + Temozolomide (NCT01517776)
- 2015-04-28Also stopped (terminated): National Cancer Institute (NCI), Cilengitide (NCT01122888)
- 2015-03-26Also stopped (withdrawn): St. Louis University, Abciximab + Placebo (NCT01932554)
- 2015-02-27Also stopped (terminated): Hospital Avicenne, TIROFIBAN (NCT00445263)
- 2015-02-09Results posted on the registry: Hospital Avicenne, TIROFIBAN (NCT00445263)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision